Literature DB >> 10767233

Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study.

B Afessa1, B Green.   

Abstract

STUDY
OBJECTIVES: To describe the causative organisms and factors associated with bacterial pneumonia and to assess its impact on the outcome of hospitalized patients with HIV.
DESIGN: Prospective, observational.
SETTING: A university-affiliated medical center.
METHODS: We included 1,225 consecutive hospital admissions, from April 1995 through March 1998, of 599 adults with HIV. We collected data on APACHE II (acute physiology and chronic health evaluation II) score, leukocyte and CD4+ lymphocyte counts, length of hospital stay, ICU admission rate, and case-fatality rate. Chest radiographs and laboratory results were reviewed. The presence of bacterial pneumonia was noted.
RESULTS: Bacterial pneumonia was diagnosed in 111 hospitalizations (9%): 80 (72%) were community-acquired infections. The CD4+ lymphocyte count was lower (median, 38 vs 66/microL, p = 0.0027), APACHE II score higher (17 vs 13, p < 0. 0001), length of hospital stay longer (median, 6 vs 4), and ICU admission (28% vs 9%) and case-fatality rates (21% vs 4%) higher in patients with bacterial pneumonia compared with those without bacterial pneumonia. The most common pathogen was Pseudomonas aeruginosa (32 admissions), followed by Streptococcus pneumoniae (22 admissions), Staphylococcus aureus (16 admissions), and Haemophilus influenzae (11 admissions). Thirty-three (30%) of the pneumonias were bacteremic. Bacteremia was more common in pneumococcal than in pseudomonal pneumonia (95% vs 9%, p < 0.0001). Compared with patients with pneumococcal pneumonia, patients with pseudomonal pneumonia had lower leukocyte and CD4+ lymphocyte counts, longer hospital stay, and similar case-fatality rate.
CONCLUSIONS: P aeruginosa is becoming a common cause of both community-acquired and nosocomial bacterial pneumonia in hospitalized patients with HIV, especially in those with low leukocyte and CD4+ lymphocyte counts.

Entities:  

Mesh:

Year:  2000        PMID: 10767233     DOI: 10.1378/chest.117.4.1017

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  31 in total

Review 1.  Pneumonia and pregnancy.

Authors:  W S Lim; J T Macfarlane; C L Colthorpe
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

Review 2.  The pulmonary physician in critical care * Illustrative case 5: HIV associated pneumonia.

Authors:  R J Boyton; D M Mitchell; O M Kon
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

3.  Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection.

Authors:  Tsuyoshi Umehara; Kosuke Kato; Yong Sung Park; Erik P Lillehoj; Hideyuki Kawauchi; Kwang Chul Kim
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

4.  Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.

Authors:  Alphonse Okwera; David K Mafigiri; David Guwatudde; Christopher Whalen; Moses Joloba
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

5.  Role of Interleukin-17 in defense against pseudomonas aeruginosa infection in lungs.

Authors:  Xilin Xu; Bing Shao; Ran Wang; Sijing Zhou; Zhongzhi Tang; Weihua Lu; Shengdao Xiong
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 6.  Evaluation of respiratory disease.

Authors:  Sofya Tokman; Laurence Huang
Journal:  Clin Chest Med       Date:  2013-04-15       Impact factor: 2.878

7.  Bacterial induction of early response genes and activation of proapoptotic factors in pleural mesothelial cells.

Authors:  Kamal A Mohammed; Najmunnisa Nasreen; Veena B Antony
Journal:  Lung       Date:  2007-10-10       Impact factor: 2.584

8.  Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone.

Authors:  Adam J Ritchie; Andrew O W Yam; Kara M Tanabe; Scott A Rice; Margaret A Cooley
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Acute alcohol intoxication suppresses the pulmonary ELR-negative CXC chemokine response to lipopolysaccharide.

Authors:  Kyle I Happel; Xiaowen Rudner; Lee J Quinton; Jennifer L Movassaghi; Charles Clark; Anthony R Odden; Ping Zhang; Gregory J Bagby; Steve Nelson; Judd E Shellito
Journal:  Alcohol       Date:  2007-08       Impact factor: 2.405

10.  Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit.

Authors:  Julio Croda; Mariana Garcia Croda; Alan Neves; Sigrid De Sousa dos Santos
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.